Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-01

FDA Approved: FOSCARNET SODIUM — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original ANDA for Foscarnet sodium from Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSCARNET SODIUM (Foscarnet sodium)

Snippet

ORIG AP for FOSCARNET SODIUM (FOSCARNET SODIUM)